Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Squalamine Lactate in Wet AMD
NCT00333476Phase 2Terminated
- Sponsor
- Genaera Corporation
- Start
- May 2006
- Modality
- Multivalent & Scaffold-Based Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of squalamine in exudative macular degeneration, sponsored by Genaera Corporation. Started May 2006; status: terminated.
02
Drugs
squalamine
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT00333476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333476.